SEC Form 4 · accession 0000899243-18-030796
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rita Jain
Officer — SVP, Chief Medical Officer
Period of report
Dec 12, 2018
Accepted (ET)
Dec 13, 2018 · 8:17 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001517022
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2018 | F | 8,659 | $8.94 | D | 20,741 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24- Power of Attorney